SMTL ID : 4o0v.1

Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 2OL: 1-({1-(2-AMINOPYRIMIDIN-4-YL)-2-[(2-METHOXYETHYL)AMINO]-1H-BENZIMIDAZOL-6-YL}ETHYNYL)CYCLOHEXANOL(Non-covalent)

2OL.1: 18 residues within 4Å: Chain A: I.29, G.30, V.37, A.50, K.52, E.68, V.81, M.83, M.97, E.98, F.99, L.100, G.103, A.104, L.149, S.159, D.160, F.161 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.37, A:A.50, A:M.83, A:L.149, A:F.161 Hydrogen bonds: A:K.52, A:E.68, A:L.100, A:L.100, A:F.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Staben, S.T. et al., Back Pocket Flexibility Provides Group II p21-Activated Kinase (PAK) Selectivity for Type I 1/2 Kinase Inhibitors. J.Med.Chem. (2014)

Release Date

2014-02-12

Peptides

Serine/threonine-protein kinase PAK 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PAK 4

Related Entries With Identical Sequence